human
rhinovirus
hrv
well
accept
major
caus
common
cold
syndrom
rhiniti
role
etiolog
lower
respiratori
tract
infect
still
controversi
detect
asymptomat
patient
rel
common
hrv
pathogen
role
four
group
hospit
patient
pediatr
immunocompet
immunocompromis
patient
adult
immunocompet
immunocompromis
patient
investig
quantifi
hrv
load
nasopharyng
aspir
bronchoalveolar
lavag
sampl
realtim
revers
transcript
pcr
rtpcr
realtim
rtpcr
perform
duplic
respiratori
sampl
result
posit
qualit
rtpcr
addit
molecular
type
allow
detect
known
hrv
speci
b
c
immunocompet
pediatr
patient
hrv
mostli
associ
lower
respiratori
tract
infect
absenc
viral
agent
wheez
viral
load
rna
copiesml
young
immunocompromis
patient
stem
cell
transplant
recipi
invers
correl
hrv
persist
time
time
infect
occur
transplant
observ
wherea
adult
immunocompromis
patient
lung
transplant
recipi
hrv
could
detect
mediumlow
level
rna
copi
ml
bronchoalveolar
lavag
sampl
taken
routin
asymptomat
patient
conclus
detect
high
viral
load
hrv
may
caus
sever
upper
lower
respiratori
tract
infect
wherea
detect
mediumlow
viral
load
event
frequent
immunocompromis
subject
may
repres
bystand
virus
follow
identif
human
rhinovirus
hrv
mostli
consid
respons
agent
common
cold
syndrom
thu
minor
impact
human
patholog
howev
recent
pathogen
role
repeatedli
claim
acut
sinus
adult
acut
otiti
media
children
pitkaranta
et
al
asthma
exacerb
children
adolesc
adult
nicholson
et
al
johnston
et
al
furthermor
pathogen
role
hrv
lower
respiratori
tract
infect
infant
elderli
immunocompromis
patient
report
detail
viral
pneumonia
case
neonat
attribut
hrv
abzug
et
al
well
communityacquir
pneumonia
case
hospit
children
juven
et
al
often
associ
concurr
bacteri
infect
addit
hrv
consid
second
common
caus
bronchiol
rsv
often
associ
rsv
ong
et
al
papadopoulo
et
al
furthermor
hrv
report
associ
hospit
children
histori
wheez
asthma
miller
et
al
prospect
studi
cover
followup
first
year
wheez
caus
hrv
strongest
predictor
subsequ
year
wheez
lemansk
et
al
adult
impact
hrv
infect
lower
respiratori
tract
asthma
chronic
bronchiti
cystic
fibrosi
exacerb
nicholson
et
al
collinson
et
al
seemung
et
al
report
along
frequent
associ
hrv
lower
respiratori
tract
infect
immunocompromis
host
lung
transplant
recipi
kaiser
et
al
addit
hrv
report
present
respiratori
secret
asymptomat
individu
patient
van
kraaij
et
al
recent
hrv
classifi
previous
two
genet
group
hrva
includ
serotyp
hrvb
includ
serotyp
extend
includ
third
group
hrvc
consist
mani
previous
unrecogn
noncultiv
hrv
lau
et
al
lee
et
al
present
studi
relationship
investig
hrv
load
respiratori
secret
occurr
clinic
symptom
respiratori
tract
young
immunocompet
immunocompromis
subject
well
adult
immunocompet
immunocompromis
patient
admit
hospit
patient
admit
fondazion
ircc
policlinico
san
matteo
univers
hospit
respiratori
specimen
sent
viral
diagnost
servic
routin
viral
diagnosi
patient
examin
n
classifi
four
group
pediatr
immunocompet
patient
admit
hospit
diagnosi
acut
respiratori
tract
infect
mostli
interest
lower
respiratori
tract
associ
wheez
n
ii
children
young
adult
oncohematolog
disord
acut
respiratori
tract
infect
n
n
receiv
hematopoiet
stem
cell
transplant
iii
adult
immunocompet
patient
n
admit
hospit
differ
patholog
acut
respiratori
tract
infect
iv
adult
immunocompromis
patient
n
includ
adult
stem
cell
transplant
recipi
n
acut
respiratori
tract
infect
lung
transplant
recipi
examin
either
acut
respiratori
tract
infect
follow
routin
bronchoscopi
perform
monitor
occurr
chronic
reject
n
respiratori
specimen
either
nasopharyng
aspir
bronchoalveolar
lavag
sampl
collect
novemb
may
sampl
collect
accord
standard
procedur
admiss
discharg
patient
case
also
one
followup
medic
visit
respiratori
sampl
posit
respiratori
virus
admiss
includ
even
neg
subsequ
visit
followup
period
juneoctob
includ
studi
nasopharyng
aspir
bronchoalveolar
lavag
sampl
aliquot
handl
previous
report
rovida
et
al
sarasini
et
al
respiratori
specimen
test
influenzavirus
b
flu
b
human
parainfluenzavirus
hpiv
human
respiratori
syncyti
viru
rsv
human
adenovirus
hadv
human
coronavirus
hcov
human
metapneumovirus
hmpv
monoclon
antibodi
mab
direct
fluoresc
antibodi
dfa
stain
mab
flu
b
hpiv
rsv
hadv
obtain
sourc
chemicon
intern
inc
temecula
ca
mab
hmpv
gerna
et
al
hcov
gerna
et
al
develop
laboratori
specimen
posit
dfa
quantifi
realtim
reversetranscript
pcr
rtpcr
hmpv
b
kuyper
et
al
rsv
b
perkin
et
al
addit
specimen
test
realtim
pcr
human
bocaviru
hbov
lu
et
al
respiratori
sampl
also
test
qualit
basi
hrv
method
steining
et
al
hcov
method
es
et
al
specimen
posit
hrv
quantifi
realtim
rtpcr
deffernez
et
al
final
presenc
hrvc
strain
verifi
group
young
oncohematolog
patient
sequenc
phylogenet
analysi
use
method
lee
et
al
approach
limit
group
patient
order
verifi
whether
differ
type
hrv
infect
patient
followup
rna
extract
ml
nasopharyng
aspir
bronchoalveolar
lavag
autom
extract
kit
nuclisen
easi
biom
erieux
lyon
franc
elut
ml
elut
buffer
revers
transcript
rt
viral
rna
perform
ii
rnase
hrevers
transcriptas
invitrogen
carlsbad
ca
reaction
mixtur
contain
ml
extract
rna
correspond
ml
nasopharyng
aspir
bronchoalveolar
lavag
ml
buffer
mm
trishcl
ph
mm
kcl
mm
mgcl
ml
dithiothreitol
ml
superscript
ii
rnase
hrevers
transcriptas
ml
deoxynucleosid
triphosph
mm
ml
random
primer
p
dn
ml
nucleasefre
water
final
volum
ml
rt
thermal
profil
min
c
min
c
min
c
realtim
pcr
perform
ml
cdna
correspond
ml
nasopharyng
aspir
bronchoalveolar
lavag
accord
deffernez
et
al
final
volum
ml
reaction
mixtur
contain
ml
taqman
univers
pcr
master
mix
amperas
ung
appli
biosystem
intern
foster
citi
ca
mm
forward
mm
revers
primer
mm
two
probe
primer
probe
sequenc
follow
forward
primer
revers
primer
probe
tamra
probe
tamra
thu
probe
hrva
label
end
report
dye
fam
end
quencher
dye
tamra
probe
hrvb
label
end
report
dye
vic
appli
biosystem
pe
europ
basel
switzerland
end
quencher
dye
tamra
dna
amplif
perform
micropl
use
abi
prism
sequenc
detect
system
appli
biosystem
accord
follow
thermal
profil
min
c
min
c
follow
cycl
sec
c
sec
c
realtim
rtpcr
test
run
includ
amplif
two
dna
scale
one
per
probe
consist
two
linear
plasmid
obtain
clone
two
refer
hrv
serotyp
serotyp
probe
serotyp
probe
ta
clone
kit
invitrogen
extern
standard
amplifi
dna
copi
allow
construct
two
standard
curv
amount
viral
load
present
clinic
sampl
extrapol
result
multipli
factor
refer
ml
nasopharyng
aspir
bronchoalveolar
lavag
thu
neg
result
indic
rna
copiesml
two
curv
adopt
order
detect
hrva
hrvb
group
deffernez
et
al
rtpcr
method
hrv
detect
steining
et
al
well
rtpcr
hrv
molecular
type
base
phylogenet
analysi
variabl
sequenc
noncod
region
hrv
perform
group
young
oncohematolog
patient
accord
lee
et
al
perform
report
experi
replica
mean
intraassay
interassay
coeffici
variabl
less
pcr
assay
plasmid
scale
comparison
median
perform
wilcoxon
test
pair
data
mannwhitney
utest
use
unpair
data
correl
onset
hrv
infect
transplant
durat
hrv
infect
investig
mean
nonlinear
curv
fit
analysi
winterspr
season
patient
admit
hospit
examin
respiratori
virus
nasopharyng
aspir
bronchoalveolar
lavag
sampl
whole
found
carri
one
respiratori
virus
wherea
patient
virusfre
respiratori
sampl
collect
hospit
stay
medic
control
visit
outpati
unit
total
number
respiratori
sampl
examin
posit
one
respiratori
virus
wherea
neg
sinc
fair
number
patient
follow
outpati
unit
sustain
period
time
hospit
discharg
episod
respiratori
viru
infect
consid
differ
one
anoth
patient
viru
respons
one
episod
disappear
respiratori
secret
least
week
ie
upon
two
subsequ
examin
subsequ
episod
consid
caus
differ
viru
basi
singl
infect
episod
coinfect
two
three
respiratori
virus
result
total
number
respiratori
infect
episod
two
virus
caus
far
largest
number
episod
singl
infect
coinfect
hrv
rsv
fig
c
detail
hrv
associ
episod
singl
infect
episod
coinfect
tabl
parallel
rsv
associ
episod
singl
infect
episod
coinfect
tabl
whole
hrv
rsv
associ
episod
respiratori
infect
respect
tabl
consid
episod
hrv
rsv
coinfect
total
number
respiratori
episod
involv
hrv
andor
rsv
absolut
number
patient
respiratori
sampl
examin
number
patient
sampl
posit
respiratori
virus
shown
figur
respect
accord
age
pediatr
adult
patient
immun
compet
distribut
two
repres
infect
episod
hrv
rsv
infect
coinfect
interest
immunocompet
infant
young
children
case
doubl
infect
affect
young
immunocompromis
patient
case
doubl
infect
adult
n
immunocompet
n
immunocompromis
patient
tabl
howev
absolut
number
hrv
rsv
infect
significantli
higher
young
immunocompet
patient
compar
young
immunocompromis
adult
patient
percentag
hrv
infect
compar
young
adult
immunocompet
immunocompromis
patient
contrari
percentag
rsv
infect
significantli
higher
pediatr
immunocompet
patient
compar
group
addit
ratio
hrvrsv
infect
predomin
rsv
infect
pediatr
immunocompet
patient
wherea
young
immunocompromis
patient
group
adult
ratio
greater
immunocompromis
greater
immunocompet
patient
tabl
interest
featur
relationship
observ
four
group
patient
hrv
load
clinic
symptom
report
follow
whole
patient
select
group
due
avail
followup
data
clinic
find
infant
young
immunocompet
children
episod
acut
respiratori
tract
infect
undergo
followup
admit
hospit
within
median
time
rang
day
onset
symptom
examin
within
hr
show
presenc
hrv
strain
coinfect
anoth
respiratori
viru
associ
hrv
remain
young
patient
examin
late
day
respect
onset
respiratori
episod
chronic
respiratori
infect
episod
patient
posit
hrv
show
fall
viral
load
admiss
discharg
close
associ
improv
clinic
symptom
tabl
ii
three
patient
high
viral
load
detect
singl
sampl
taken
admiss
concomitantli
acut
respiratori
symptom
howev
three
patient
viral
load
increas
remain
stabl
admiss
discharg
contrast
improv
clinic
symptom
tabl
ii
group
patient
coinfect
tabl
iv
hrv
present
differ
titer
nasopharyng
aspir
associ
anoth
respiratori
viru
patient
rsva
patient
rsvb
patient
patient
hrvassoci
viru
detect
titer
greater
rna
copiesml
nasopharyng
aspir
time
admiss
hospit
variabl
lower
titer
time
discharg
hrv
viru
detect
titer
greater
copiesml
nasopharyng
aspir
patient
four
patient
hrv
titer
decreas
discharg
respect
patient
admiss
howev
fifth
patient
hrv
titer
rose
two
addit
patient
titer
rose
hospit
stay
patient
clinic
affect
bronchiol
pneumonia
often
associ
wheez
time
admiss
time
hospit
discharg
patient
show
clinic
improv
includ
three
patient
show
rise
hrv
titer
hospit
stay
tabl
iii
shown
tabl
iv
patient
singl
hrv
infect
viral
load
significantli
higher
p
time
admiss
hospit
rna
copiesml
respect
time
dismiss
rna
copi
ml
patient
coinfect
hrv
load
compar
p
ns
admiss
copiesml
discharg
copiesml
wherea
coinfect
viru
show
viral
load
nasopharyng
aspir
admiss
copiesml
significantli
higher
p
found
discharg
copiesml
hand
admiss
hrv
load
patient
singl
infect
copiesml
significantli
higher
p
patient
coinfect
copiesml
hrv
viral
load
discharg
compar
p
patient
singl
infect
copiesml
coinfect
copiesml
coinfect
entail
greater
durat
hospit
stay
day
compar
singl
hrv
infect
day
final
addit
young
patient
delay
admiss
hospit
respect
onset
symptom
report
hrv
detect
titer
consist
lower
rna
copiesml
nasopharyng
aspir
time
admiss
hospit
provid
use
result
view
definit
current
respiratori
tract
infect
episod
symptomat
hrv
respiratori
infect
singl
infect
coinfect
concern
mani
young
oncohematolog
patient
nine
singl
infect
follow
least
month
shown
figur
invers
correl
describ
exponenti
decay
model
observ
time
day
transplant
onset
hrv
infect
durat
hrv
infect
adjust
r
patient
experienc
hrv
infect
within
day
allograft
show
high
viral
load
last
nasopharyng
aspir
sampl
test
thu
suggest
sustain
viral
excret
patient
experienc
hrv
infect
day
transplant
hrv
disappear
nasopharyng
aspir
within
week
onset
infect
howev
patient
peak
viral
load
measur
infect
differ
magnitud
viral
load
peak
observ
patient
undergo
hrv
infect
earli
posttransplant
period
three
patient
group
infect
hrvc
strain
one
patient
receiv
two
tcell
deplet
allograft
relaps
leukemia
hlahaploident
mother
die
month
transplant
due
respiratori
failur
hemorrhag
alveol
patient
infect
two
differ
hrvc
strain
one
detect
nasopharyng
secret
upon
transplant
detect
bronchoalveolar
lavag
time
death
observ
immunocompet
pediatr
patient
immunocompet
patient
adult
popul
exhibit
level
hrv
load
greater
rna
copiesml
rule
present
respiratori
symptom
interest
upper
lower
respiratori
tract
wherea
lower
viral
level
appear
correl
kinet
clinic
symptom
observ
made
followup
note
patient
low
hrv
load
becam
neg
associ
persist
clinic
symptom
patient
low
viral
load
remain
unchang
associ
improv
clinic
symptom
pathogen
role
hrv
infect
also
investig
lung
transplant
recipi
followup
patient
examin
either
nasopharyng
aspir
n
examin
acut
respiratori
tract
infect
episod
bronchoalveolar
lavag
even
absenc
symptom
follow
routin
bronchoscopi
examin
n
examin
detail
nasopharyng
aspir
five
episod
acut
upper
respiratori
tract
infect
interest
five
lung
transplant
recipi
tabl
v
found
associ
high
hrv
load
rna
copiesml
nasopharyng
aspir
upper
respiratori
secret
thu
document
associ
respiratori
hrv
load
upper
respiratori
clinic
symptom
infecti
agent
detect
patient
hand
remain
seven
patient
three
respiratori
tract
infect
show
hrv
load
rna
copiesml
bronchoalveolar
lavag
four
patient
free
acut
respiratori
symptom
lower
respiratori
tract
viral
load
rna
copiesml
bronchoalveolar
lavag
find
document
hrv
presenc
lower
respiratori
tract
absenc
overt
clinic
symptom
tabl
v
clinic
followup
exclud
possibl
low
hrv
amount
detect
bronchoalveolar
lavag
patient
relat
end
previou
lower
respiratori
tract
infect
episod
onset
new
respiratori
infect
episod
occur
lower
respiratori
tract
result
present
studi
focus
analysi
correl
hrv
load
respiratori
secret
presenceabs
clinic
symptom
limit
winterspr
season
allow
formul
gener
conclus
viral
load
greater
hrv
rna
copiesml
nasopharyng
aspir
appear
mostli
associ
presenc
clinic
symptom
upper
lower
respiratori
infect
ii
immunocompet
infant
young
children
case
hrv
rsv
coinfect
quantif
viral
load
allow
hypothes
viral
agent
respons
current
respiratori
episod
requir
adopt
adequ
therapeut
measur
iii
young
stem
cell
transplant
recipi
followup
allow
detect
invers
correl
time
transplant
durat
hrv
infect
peak
viral
load
influenc
time
elaps
transplant
occurr
viral
infect
iv
adult
lung
transplant
recipi
examin
bronchoalveolar
lavag
posttranspl
followup
hrv
load
lower
fig
invers
correl
durat
day
hrv
infect
time
day
elaps
stem
cell
transplant
prior
onset
hrv
infect
nine
young
patient
patient
vertic
arrow
indic
hrv
persist
time
last
viral
control
wherea
hrv
disappear
indic
patient
peak
hrv
load
detect
respiratori
secret
patient
report
rna
copiesml
appear
associ
presenc
clinic
symptom
detect
larger
viral
load
lot
debat
regard
presenc
hrv
respiratori
tract
asymptomat
children
adult
blomqvist
et
al
noksokoivisto
et
al
kusel
et
al
rawlinson
et
al
van
benten
et
al
winther
et
al
use
molecular
assay
given
durat
hrv
shed
around
infect
episod
incident
hrv
detect
independ
hospit
may
occur
frequent
turner
event
may
occur
individu
recent
experienc
respiratori
symptom
contact
household
member
acut
respiratori
tract
infect
patient
develop
symptom
sampl
howev
even
exclud
individu
estim
overal
appar
healthi
children
picornavirusrnaposit
absenc
previou
incipi
respiratori
symptom
noksokoivisto
et
al
order
address
clinic
signific
hrv
present
respiratori
tract
decid
quantifi
hrv
load
respiratori
secret
correl
viral
load
clinic
symptom
found
viral
load
greater
rna
copiesml
nasopharyng
aspir
appear
associ
presenc
clinic
symptom
either
interest
upper
lower
respiratori
tract
viral
load
lower
copiesml
infrequ
associ
clinic
symptom
experiment
condit
shown
hrv
abl
grow
lower
respiratori
tract
demonstr
abil
grow
vitro
primari
human
bronchial
epitheli
cell
schroth
et
al
papadopoulo
et
al
vivo
lower
airway
secret
follow
experiment
infect
intranas
instil
aerosol
gern
et
al
papadopoulo
et
al
addit
shown
bronchoscopi
sampl
viru
titer
similar
observ
nasal
brush
sampl
halperin
et
al
find
support
assumpt
viru
quantit
nasopharyng
aspir
lower
respiratori
tract
infect
mirror
viru
amount
present
lower
respiratori
tract
along
line
thought
appear
reason
attribut
etiolog
role
lower
respiratori
episod
hrv
whenev
high
viral
load
detect
nasopharyng
aspir
patient
shed
virus
respiratori
secret
report
deffernez
et
al
hrv
serotyp
test
n
clinic
isol
detect
assay
howev
possibl
exclud
lower
sensit
detect
serotyp
includ
belong
recent
identifi
group
c
studi
amplicon
sequenc
thu
show
abil
assay
detect
strain
belong
b
c
speci
hrv
mani
episod
dual
hrv
rsv
three
episod
third
viru
detect
coinfect
observ
previou
studi
bronchiol
greater
diseas
sever
report
admiss
patient
coinfect
compar
patient
singl
infect
andreoletti
et
al
papadopoulo
et
al
studi
hrv
rsv
coinfect
predomin
among
combin
coinfect
viru
quantif
allow
hypothes
rsv
etiolog
agent
acut
respiratori
episod
hrv
present
lower
amount
like
consid
bystand
viru
respect
current
respiratori
infect
episod
although
rel
infrequ
two
virus
detect
high
concentr
respiratori
secret
rna
copiesml
npa
experi
indic
absolut
valu
viral
load
admiss
sampl
kinet
viral
load
drop
associ
improv
clinic
symptom
may
discrimin
among
two
three
coinfect
virus
etiolog
agent
respiratori
syndrom
gerna
et
al
present
studi
hrv
second
common
respiratori
viru
caus
hospit
immunocompet
children
rsv
children
singl
hrv
infect
almost
constant
associ
wheez
andor
pneumonia
appear
confirm
recent
publish
data
frequenc
hrvassoci
hospit
young
children
miller
et
al
studi
report
rate
hrvassoci
hospit
children
year
age
rate
increas
month
year
age
higher
children
histori
wheezingasthma
howev
whether
hrv
infect
predispos
asthma
patient
asthma
suscept
hrv
infect
remain
defin
current
studi
confirm
children
predisposit
wheezingasthma
risk
hospit
affect
hrv
infect
median
durat
hrv
ill
day
patient
howev
experi
durat
two
stem
cell
transplant
recipi
repeat
bronchoalveolar
lavag
sampl
hrvposit
interv
day
first
viru
detect
find
rais
possibl
prolong
lower
respiratori
tract
replic
ison
et
al
present
studi
abl
detect
invers
correl
durat
hrv
infect
time
day
elaps
transplant
group
nine
young
stem
cell
transplant
recipi
follow
least
month
find
support
recommend
feasibl
delay
transplant
least
month
hrv
detect
nasopharyng
aspir
period
preced
begin
prepar
regimen
allograft
hand
peak
viral
load
influenc
time
elaps
transplant
past
case
respiratori
failur
along
hrv
respiratori
infect
either
associ
copathogen
attribut
chemotherapyradiotherapi
ghosh
et
al
ison
et
al
van
kraaij
et
al
howev
two
case
fatal
lower
respiratori
tract
infect
adult
stem
cell
transplant
recipi
like
caus
hrv
recent
report
peck
et
al
studi
patient
one
surviv
hrv
infect
followup
case
transplant
patient
succumb
pneumonia
follow
hrvc
infect
underscor
potenti
sever
pathogen
role
newli
identifi
group
hrv
lau
et
al
lee
et
al
final
group
lung
transplant
recipi
examin
longterm
followup
document
even
lower
respiratori
tract
secret
presenc
low
hrv
amount
associ
overt
clinic
symptom
contrast
consist
observ
presenc
higher
viral
load
data
previous
report
prognost
impact
hrv
present
bronchoalveolar
lavag
lung
transplant
recipi
contradictori
holt
et
al
malcolm
et
al
find
may
help
clarifi
issu
conclus
studi
show
hrv
quantit
nasopharyng
aspir
appear
correl
clinic
symptom
associ
lower
respiratori
tract
infect
ii
hrv
rsv
coinfect
appear
worsen
prognosi
lower
respiratori
tract
infect
episod
iii
young
stem
cell
transplant
recipi
invers
correl
durat
hrv
infect
time
infect
occur
transplant
observ
iv
lung
transplant
recipi
hrv
load
bronchoalveolar
lavag
appear
correl
clinic
symptom
